BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2019
View Archived Issues
Clotbuster's clot-busting may be beside the point
Read More
Preclinical results of a systemic mRNA therapy for Fabry disease
Read More
Discovery of novel selective hematopoietic prostaglandin D synthase inhibitors
Read More
Takeda's TAK-981 inhibits SUMOylation in vivo, heads to phase I
Read More
Sun Yat-sen University describes mesenchymal stem cells overexpressing CCR2
Read More
AEBi Accelerated Evolution Biotechnologies presents cytotoxic peptides
Read More
New NLRP3 inflammasome inhibitors patented by Inflazome
Read More
Theralase initiates phase II study of TLD-1433 in nonmuscle-invasive bladder cancer
Read More
Prevail Therapeutics describes glucocerebrosidase constructs
Read More
New regenerative therapy developed for Strep pneumonia
Read More
Rapid diagnosis of rare diseases
Read More
KIAA0125 found to be a diagnostic marker in ameloblastoma
Read More
Preclinical characterization of a novel oHSV-expressing bispecific antibody, ONCR-148
Read More
ARHGEF2 as a novel prognosis marker in pancreatic cancer
Read More
Novel animal model of advanced NASH mimics main characteristics of human disease
Read More
FDA approves intravenous Benlysta for pediatric SLE
Read More
FDA approves Praluent to reduce risk of heart attack, stroke and unstable angina
Read More
First-in-human trial scheduled for TGF-beta receptor type-1 inhibitor GFH-018
Read More
Guangdong Zhongsheng Pharmaceutical completes phase I study of ZSP-1273
Read More
Novo Nordisk reports phase III results with Victoza in pediatric type 2 diabetes
Read More
AstraZeneca and Ionis Pharmaceuticals collaborate on antisense oligonucleotide targeting FOXP3
Read More
4D Pharma offers update on development of MRx-0518
Read More
European Commission approves Zynquista for type 1 diabetes
Read More
Conditional marketing authorization granted in E.U. for Ondexxya to reverse factor Xa inhibitors
Read More
Maruishi reports results from Japanese phase III study of Traumakine in ARDS
Read More
ObsEva reports follow-up data from phase III IMPLANT2 study of nolasiban
Read More
Omeicos doses first patient in phase II study of OMT-28 for atrial fibrillation
Read More